profession

IRB disclosure policies, review procedures found lacking

Many academic institutional review boards don't require reporting of financial conflicts, a new study finds. A federal probe highlights lapses in the IRB process.

By Kevin B. O’Reilly — Posted April 27, 2009

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

Two new reports shed harsh light on the institutional review boards that are charged with protecting human research subjects from harm.

The Assn. of American Medical Colleges in 2001 recommended that IRB members disclose any financial conflicts, yet 27.4% of review boards still do not require it, according to a survey of 107 IRB chairs reported in the April Academic Medicine.

"We've been talking about conflicts of interest in clinical research for almost 20 years now, and the fact that nearly 30% of IRBs in medical schools don't have policies that require disclosure is completely astounding to me," said Eric G. Campbell, PhD, senior author of the study and associate professor of medicine at Harvard Medical School in Boston.

More than 20% of IRBs lack a written policy that defines conflicts of interest, and there is confusion about whose responsibility it is to determine when a member's relationship with industry constitutes a conflict.

While IRB chairs said members with a conflict never voted on proposed research protocols, a companion survey of IRB members found that 20% said they always voted, despite the presence of a personal conflict.

"IRBs are, frankly, pretty confused about what they should be doing," said Christine Vogeli, PhD, a study co-author and instructor of medicine at Harvard Medical School. "It really speaks to the need to clearly provide guidance that can be very well-digested."

Last year the AAMC and the Assn. of American Universities issued joint guidelines on reporting financial conflicts, saying that any potential conflict should be reported, no matter how small the amount of money involved. The AAMC did not grant an interview request by this article's deadline.

Sting highlights "IRB shopping"

Meanwhile, a Government Accountability Office investigation released in late March found that "the IRB system is vulnerable to unethical manipulation, which elevates the risk that experimental products are approved for human subject tests without full and appropriate review."

The GAO, in a sting operation, set up a Web site for a bogus IRB and heard from a medical research company seeking its services, "even though GAO's investigators had no medical expertise whatsoever," the agency's report said.

GAO investigators also got approval from an IRB for a fictitious medical device with fake specifications that would fall under the Food and Drug Administration's "significant risk" category of devices.

"We basically said we're shopping for an IRB to give us a quick turnaround on a new device," which was presented as legitimate, said Gregory D. Kutz, the GAO's managing director of forensic audits and special investigations.

Two of three IRBs rejected the protocol, describing it as "awful," a "piece of junk," and "the worst I've seen ... too risky."

But Colorado Springs, Colo.-based Coast Independent Review Board LLC unanimously approved the research protocol. "It was pretty much a rubber stamp," Kutz said.

Coast IRB CEO David Deuber said in a statement, responding to the GAO report, that "across-the-board changes to procedures governing intake and evaluation of clinical trials are needed." The company stopped considering new research protocols for 30 days -- through May 1 -- "as part of an intensive review of Coast IRB's [standard operating procedures] and internal processes," the company's Web site said.

Back to top


ADDITIONAL INFORMATION

Managing IRB conflicts

An anonymous survey of more than 100 institutional review board chairs found that many IRBs still do not have conflict-disclosure procedures or written policies.

Does the IRB have a defined process for members to disclose financial and other industry relationships?

Yes: 74.5%
No: 25.5%

Does the IRB have a written policy defining conflicts of interest?

Yes: 68.2%
No: 24.4%
Don't know: 9.3%

Source: "Policies and Management of Conflicts of Interest Within Medical Research Institutional Review Boards: Results of a National Study," Academic Medicine, April (link)

Back to top


External links

"Policies and Management of Conflicts of Interest Within Medical Research Institutional Review Boards: Results of a National Survey," abstract, Academic Medicine, April (link)

"Protecting Patients, Preserving Integrity, Advancing Health: Accelerating the Implementation of COI Policies in Human Subjects Research," Assn. of American Medical Colleges-Assn. of American Universities Advisory Committee on Financial Conflicts of Interest in Human Subjects Research, February 2008 (link)

"Human Subjects Research: Undercover Tests Show the Institutional Review Board System Is Vulnerable to Unethical Manipulation," Government Accountability Office, March 26 (link)

House Committee on Energy and Commerce Subcommittee on Oversight and Investigations' hearing, "Institutional Review Boards that Oversee Experimental Human Testing for Profit," March 26 (link)

Coast Independent Review Board LLC (link)

Back to top


ADVERTISEMENT

ADVERTISE HERE


Featured
Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story


Read story

Goodbye

American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story


Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story


Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story


Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story


Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story


Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story


Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn